Platform revamp bet: growth stalls, capital deployed, execution unproven

Delivered ₹88.3 Cr, YoY +13.7% (not 14%)

Delivered ₹11.6 Cr PAT, exact match

QoQ revenue only +3.4%, PAT +6.6%; no specific recovery timeline given

MF AUM at ₹2,073 Cr (+18% QoQ); specific MTF book not in delivered result

No RPC/LTV metrics in delivered result; claimed in Q&A but unverified

Prior guidance was strategic intent; this call confirmed ₹227 Cr to exchange margin (RBI mandate), ₹150 Cr debt, ₹88 Cr corporate—providing transparency on allocation.

Q1 PAT grew only 0.2% YoY vs prior expectations of benefit from capital raise and product initiatives; OPM flat at 29.5% suggests expense discipline losing.

Not mentioned in prior calls; now central to growth narrative. Beta results cited as 'very encouraging' but unspecified; execution risk high.

Slightly one-off due to market volatility; we expect growth to accelerate given product improvements and growth marketing efforts.

Focus on quality over quantity; seeing improvement in RPC and LTV; long-term customers drive high ADTO; will continue this approach.

Hard to say precisely; after F&O regulation changes in Oct '24, moderation across board; our strategy is quality retention and MTF; long-term market will grow.

₹227 Cr for exchange margin (RBI mandate), ₹150 Cr debt repayment, ₹88 Cr corporate purpose (product, tech, marketing). Already deployed.

Platform revamp (happening, beta results very encouraging), growth marketing spend (now well-positioned post-capital raise), couple of pipeline products coming; MTF already showing traction.

Focus on quality organic and paid channels; refining channel mix quarterly based on CAC/RPC metrics; organic works best but takes time.

Not in near future; hands full with core platform. Mid-term, might explore if synergies exist. Focus on products adjacent to core (MTF, LAS) first.

Vague timeline ('from these quarters on'); tied to unproven product ramps (platform revamp, AlgoSpace, pipeline products).

Management says pursuing 'meaningful improvements in unit economics' but no numbers or timeline; Q1 PAT flat suggests execution challenge.

Capital deployment plan clear; execution against it (ROI on marketing, product adoption) is the variable.

Platform revamp positioned as key growth driver; beta results 'very encouraging' but unspecified. AlgoSpace targeting retail algo adoption (first-time builders); unknown market size. If adoption falls short, growth target missed.

F&O regulatory change (Oct '24, RBI intraday ban) caused ADTO dip on F&O; past year 'choppy'. Q1 showed market moderation effect; future quarters subject to equity bull/bear cycles.

PAT grew only 0.2% YoY despite 13.7% revenue growth; suggests operating expense rise (likely product/tech/marketing investment). If ROI on this spend is low, PAT leverage will not materialize.

Management acknowledged 'slowness' in customer acquisition and ADTO growth; pivoted to quality over quantity strategy. If quality strategy is defensive (not growth-oriented), headline growth will remain muted.

Management acknowledged 'some people have gained market share, some people have lost' post-F&O regulation. Large brokers have scale and capital; 5paisa's quality positioning may not be sufficient if price competition intensifies.